We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
How to use a cost effectiveness analysis to evaluate your digital health product.
The What Works Network uses evidence to improve the design and delivery of public services.
Data on the real-world efficacy of the COVID-19 vaccines.
How to use a micro-randomised trial to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
Ofsted has today published the findings from phase 2 of its independent review of teachers’ professional development in schools.
Information for patients, healthcare professionals and developers of new medicines
Guidance on choosing evaluation study types and methods.
Provides guidance on making effective use of land, including planning for higher density development.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
How to use an N-of-1 study to evaluate your digital health product.
Refreshed checklist of efficiency measures for more cost effective prescribing.
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
The Civil Service Leadership Academy immersive learning series.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).